The Clinical Epidemiology Unit (CEU) conducts etiologic research with potential clinical and public health applications, and leads studies evaluating population-based early detection and cancer prevention strategies.
CEU has a strong focus on studies of absolute cancer risk, ranging from discovery of risk markers to assay development and evaluation, with the goal of guiding promising markers into clinical and public health use. Risk markers may include genetics, epidemiologic factors, molecular biomarkers, imaging, or any routine clinical test. The risk estimates ultimately inform the development of risk-based guidelines. CEU investigators are actively involved in developing screening and management guidelines for gynecological cancers.
Current research areas include:
For more information, contact Nicolas Wentzensen, head, Clinical Epidemiology Unit